Quantcast

Latest Sexual arousal Stories

2014-04-21 08:23:38

SAN JOSE, Calif., April 21, 2014 /PRNewswire/ -- Men's health professional and author Douglas Ginter believes that sexual function is a reliable barometer of overall health, a connection that's too often overlooked. "Total Male: Save Your Life by Taking Charge of Your Sexual Health," co-written with Mark Weis, MD, explains in layman's terms how men's sexual health issues can degrade quality of life, endanger overall health and wellness, and damage lives and relationships. "Total Male"...

2014-03-31 09:43:07

Men suffering from sexual dysfunction can be successful at reversing their problem, by focusing on lifestyle factors and not just relying on medication, according to research at the University of Adelaide. In a new paper published in the Journal of Sexual Medicine, researchers highlight the incidence of erectile dysfunction and lack of sexual desire among Australian men aged 35-80 years. Over a five-year period, 31% of the 810 men involved in the study developed some form of erectile...

2014-03-27 23:01:03

Hypoactive Sexual Desire Disorder is often misunderstood and misdiagnosed. The multi-segment education initiative from Omnia Education aims to improve knowledge and awareness in healthcare professionals. Fort Washington, PA (PRWEB) March 27, 2014 More than 10% of premenopausal women may suffer from Hypoactive Sexual Desire Dysfunction (HSDD), and healthcare professionals often do not fully understand the disorder or misdiagnose patients. Omnia Education, the leading U.S. provider of...

2014-03-26 08:25:40

SAN JOSE, Calif., March 26, 2014 /PRNewswire/ -- "Total Male: Save Your Life by Taking Charge of Your Sexual Health" offers simple and effective treatment advice for the sexual health issues that men experience most. Co-authored by leading health and wellness writing team Douglas Ginter and Mark Weis, MD, this eye-opening new book is currently available on Amazon. The book will also soon be available at Barnes & Noble. Photo - http://photos.prnewswire.com/prnh/20140326/PH90863-a...

2014-03-03 08:31:34

Orexa will be the first drug ever to enter clinical trials for male HSDD JERSEY CITY, N.J., March 3, 2014 /PRNewswire/ -- S1 Biopharma today announced its plan to initiate Phase 2a clinical trials in the third quarter of this year for Orexa (S1P-205), its first-in-class therapy to treat male Hypoactive Sexual Desire Disorder (HSDD). The double-blind placebo-controlled study will be the first to evaluate a drug for male HSDD. Key points: -- Hypoactive sexual desire disorder is a sexual...

2014-02-24 08:27:59

Data from first-in-class investigational treatment presented at the International Society for the Study of Women's Sexual Health (ISSWSH) Conference in San Diego CRANBURY, N.J., Feb. 24, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) presented new analyses from its Phase 2b clinical trial of bremelanotide, which demonstrated dose-dependent improvements in sexual desire and treatment satisfaction in premenopausal women with hypoactive sexual desire disorder (HSDD) and combined...

Sexual Dysfunction Doesn't Stop A Woman From Having A Good Time
2014-02-12 04:33:10

Lee Rannals for redOrbit.com - Your Universe Online Even middle age women who have been diagnosed with sexual dysfunction continue to be sexually active, according to a new study. Researchers studied 354 middle-aged and older women who had taken a test called the Female Sexual Function Index. This test is designed to diagnose women’s sexual problems, asking questions about arousal, orgasm, vaginal lubrication and pain during intercourse. All of the women had reported being sexually...

2014-02-11 12:26:47

Women's Groups Call on FDA to Restore Gender Equity in the Treatment of Sexual Disorders WASHINGTON, Feb. 11, 2014 /PRNewswire-USNewswire/ -- In response to the U.S. Food and Drug Administration's (FDA) decision to further delay approval of the first-ever drug to treat the most common female sexual disorder, the National Consumers League and the National Organization for Women, joined by women's health and advocacy organizations, are calling on the FDA to move swiftly to end the 16...

2014-02-11 08:31:56

Agency Proposes Select Phase I Studies as Part of Resubmission RALEIGH, N.C., Feb. 11, 2014 /PRNewswire/ -- Sprout Pharmaceuticals announced today that their Formal Dispute Resolution, which was filed in December 2013, resulted in clear guidance from the FDA on the path forward. Sprout will resubmit the New Drug Application (NDA) for flibanserin, a once-daily treatment for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women, by the third quarter. The FDA has requested...

2014-01-30 08:31:26

CRANBURY, N.J., Jan. 30, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunctions will be presented at the 16(th) Congress of the European Society for Sexual Medicine in Istanbul, Turkey on Friday, January 31, 2014 at 3:25 PM local time. Dr. Michael L. Krychman from Southern California Center for...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'